A detailed history of Interchange Capital Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Interchange Capital Partners, LLC holds 3,008 shares of AZN stock, worth $214,289. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,008
Previous 3,079 2.31%
Holding current value
$214,289
Previous $240,000 2.5%
% of portfolio
0.08%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$76.67 - $87.62 $5,443 - $6,221
-71 Reduced 2.31%
3,008 $234,000
Q2 2024

Jul 31, 2024

BUY
$66.81 - $80.83 $205,707 - $248,875
3,079 New
3,079 $240,000
Q1 2021

May 05, 2021

SELL
$47.16 - $54.44 $89,981 - $103,871
-1,908 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$48.52 - $58.02 $92,576 - $110,702
1,908 New
1,908 $95,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $221B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Interchange Capital Partners, LLC Portfolio

Follow Interchange Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Interchange Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Interchange Capital Partners, LLC with notifications on news.